Jade Biosciences Aktie
WKN DE: A416MP / ISIN: US0080642061
01.07.2025 15:15:48
|
Jade Biosciences Names Brad Dahms As CFO
(RTTNews) - Jade Biosciences, Inc. (JBIO), a biotechnology company, on Tuesday announced that it has appointed Brad Dahms as Chief Financial Officer.
Dahms was most recently the Chief Financial Officer and Chief Business Officer of IDRx. Dahms had also worked at Theseus Pharmaceuticals as CFO.
On Monday, Jade Bioscience closed trading, 8.71% higher at $9.99 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Jade Biosciencesmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Jade Biosciencesmehr Analysen
Aktien in diesem Artikel
Jade Biosciences | 9,08 | -3,40% |
|